360 results on '"Moghimi,S Moein"'
Search Results
2. Activation of the complement system by nanoparticles and strategies for complement inhibition
3. Omega-3 fatty acid nanocarriers: Characterization and potential applications
4. Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions
5. Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles
6. Anti-Poly(ethylene glycol) (PEG) Antibodies: From Where Are We Coming and Where Are We Going.
7. Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin
8. Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants
9. Complement opsonization of nanoparticles: Differences between humans and preclinical species
10. Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts
11. Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants
12. Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions.
13. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions *
14. Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55
15. Intrinsic and Dynamic Heterogeneity of Nonlamellar Lyotropic Liquid Crystalline Nanodispersions
16. Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins
17. Validation of dot blot immunoassay for measurement of complement opsonization of nanoparticles
18. The Art of Complement: Complement Sensing of Nanoparticles and Consequences
19. Lactate Dehydrogenase Assay for Assessment of Polycation Cytotoxicity
20. Determination of Polycation-Mediated Perturbation of Mitochondrial Respiration in Intact Cells by High-Resolution Respirometry (Oxygraph-2k, OROBOROS)
21. Combined Fluorimetric Caspase-3/7 Assay and Bradford Protein Determination for Assessment of Polycation-Mediated Cytotoxicity
22. AFM visualization of sub-50 nm polyplex disposition to the nuclear pore complex without compromising the integrity of the nuclear envelope
23. Perspectives on complement and phagocytic cell responses to nanoparticles:From fundamentals to adverse reactions
24. Intrinsic and Dynamic Heterogeneity of Nonlamellar Lyotropic Liquid Crystalline Nanodispersions
25. Soluble and immobilized graphene oxide activates complement system differently dependent on surface oxidation state
26. An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
27. Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide
28. Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice
29. Engineering Liposomes and Nanoparticles for Biological Targeting
30. Hypersensitivity Reactions to Nanomedicines: Causative Factors and Optimization of Design Parameters
31. Factors Controlling Pharmacokinetics of Intravenously Injected Nanoparticulate Systems
32. Striking Circulating Tumour Cells during Sleep
33. Critical issues and pitfalls in serum and plasma handling for complement analysis in nanomedicine and bionanotechnology
34. Structural profiling and biological performance of phospholipid–hyaluronan functionalized single-walled carbon nanotubes
35. Complement monitoring of Pluronic 127 gel and micelles: Suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and B-100
36. Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents
37. Perspectives on carbon nanotube-mediated adverse immune effects
38. Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forward
39. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective
40. Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on “Pseudovirus-like” Nanoparticles
41. Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues
42. Material properties in complement activation
43. Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells
44. Hyaluronan-coated nanoparticles: The influence of the molecular weight on CD44-hyaluronan interactions and on the immune response
45. The Role of Complement in Antibody Therapy for Infectious Diseases
46. Tissue Specific Serum Opsonins and Phagocytosis of Liposomes
47. Nanoparticles in Medicine
48. Contributors
49. Microneedle-based devices for point-of-care infectious disease diagnostics
50. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.